US Stock MarketDetailed Quotes

HSDT Helius Medical Technologies

Watchlist
  • 4.8150
  • -0.1650-3.31%
Close Apr 24 16:00 ET
  • 4.8900
  • +0.0750+1.56%
Post 17:09 ET
4.27MMarket Cap-330P/E (TTM)

Helius Medical Technologies Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
Total revenue
-18.17%644K
-52.48%134K
-27.04%143K
115.13%256K
-41.58%111K
50.77%787K
9.30%282K
79.82%196K
67.61%119K
126.19%190K
Operating revenue
-22.24%605K
-56.23%123K
-32.31%132K
105.04%244K
-42.08%106K
57.81%778K
11.95%281K
91.18%195K
88.89%119K
117.86%183K
Cost of revenue
25.92%583K
-40.00%90K
85.15%187K
109.09%184K
-1.61%122K
55.37%463K
16.28%150K
17.44%101K
31.34%88K
726.67%124K
Gross profit
-81.17%61K
-66.67%44K
-146.32%-44K
132.26%72K
-116.67%-11K
44.64%324K
2.33%132K
313.04%95K
675.00%31K
-4.35%66K
Operating expense
-18.25%12.33M
-18.24%2.29M
-29.61%2.95M
-4.91%3.29M
-17.95%3.8M
-17.88%15.08M
-33.80%2.8M
-4.66%4.19M
-43.91%3.46M
29.69%4.63M
Selling and administrative expenses
-12.87%9.27M
-17.03%1.63M
-35.28%2.2M
4.39%2.57M
1.95%2.87M
-12.61%10.64M
-17.21%1.97M
18.68%3.39M
-48.12%2.46M
28.31%2.82M
Research and development costs
-30.97%2.94M
-18.14%650K
-3.86%722K
-28.23%684K
-49.77%886K
-28.85%4.26M
-56.08%794K
-49.56%751K
-30.79%953K
34.04%1.76M
Depreciation amortization depletion
-35.36%117K
-80.00%8K
-31.91%32K
-19.15%38K
-17.02%39K
-9.50%181K
-14.89%40K
-2.08%47K
-4.08%47K
-17.54%47K
-Depreciation and amortization
-35.36%117K
-80.00%8K
-31.91%32K
-19.15%38K
-17.02%39K
-9.50%181K
-14.89%40K
-2.08%47K
-4.08%47K
-17.54%47K
Operating profit
16.87%-12.27M
15.85%-2.25M
26.90%-2.99M
6.15%-3.22M
16.52%-3.81M
18.65%-14.76M
34.93%-2.67M
6.33%-4.1M
44.37%-3.43M
-30.36%-4.56M
Net non-operating interest income expense
130.82%257K
0
107.40%68K
89K
100K
-834K
85K
-919K
0
0
Total other finance cost
-130.82%-257K
--0
-107.40%-68K
---89K
---100K
--834K
---85K
--919K
----
----
Other net income (expense)
107.89%3.16M
152.17%1.2M
-118.49%-737K
490.00%1.48M
457.80%1.22M
15,110.00%1.52M
-2.3M
1,369.11%3.99M
-305.41%-380K
56.83%218K
Gain on sale of security
42.71%3.24M
148.87%1.13M
-112.34%-585K
490.00%1.48M
460.37%1.22M
22,610.00%2.27M
---2.31M
1,610.19%4.74M
-305.41%-380K
56.12%217K
Special income (charges)
79.00%-159K
--0
79.00%-159K
----
----
---757K
--0
---757K
----
----
-Less:Impairment of capital assets
-79.00%159K
--0
-79.00%159K
----
----
--757K
--0
--757K
----
----
Other non- operating income (expenses)
1,042.86%80K
1,116.67%73K
--7K
----
----
--7K
--6K
----
----
--1K
Income before tax
37.11%-8.85M
78.61%-1.05M
-255.63%-3.66M
56.75%-1.65M
42.61%-2.49M
22.39%-14.07M
-19.11%-4.89M
78.02%-1.03M
36.30%-3.81M
-29.27%-4.35M
Income tax
0
0
0
0
0
0
0
0
0
0
Net income
37.11%-8.85M
78.61%-1.05M
-255.63%-3.66M
56.75%-1.65M
42.61%-2.49M
22.39%-14.07M
-19.11%-4.89M
78.02%-1.03M
36.30%-3.81M
-29.27%-4.35M
Net income continuous Operations
37.11%-8.85M
78.61%-1.05M
-255.63%-3.66M
56.75%-1.65M
42.61%-2.49M
22.39%-14.07M
-19.11%-4.89M
78.02%-1.03M
36.30%-3.81M
-29.27%-4.35M
Minority interest income
Net income attributable to the parent company
37.11%-8.85M
78.61%-1.05M
-255.63%-3.66M
56.75%-1.65M
42.61%-2.49M
22.39%-14.07M
-19.11%-4.89M
78.02%-1.03M
36.30%-3.81M
-29.27%-4.35M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
37.11%-8.85M
78.61%-1.05M
-255.63%-3.66M
56.75%-1.65M
42.61%-2.49M
22.39%-14.07M
-19.11%-4.89M
78.02%-1.03M
36.30%-3.81M
-29.27%-4.35M
Basic earnings per share
72.07%-14.56
88.71%-0.96
-89.31%-5.49
93.81%-3
92.17%-4.5
85.87%-52.13
87.02%-8.5
97.11%-2.9
62.40%-48.5
30.30%-57.5
Diluted earnings per share
72.07%-14.56
88.71%-0.96
-89.31%-5.49
93.81%-3
92.17%-4.5
85.87%-52.13
87.02%-8.5
97.11%-2.9
62.40%-48.5
30.30%-57.5
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022
Total revenue -18.17%644K-52.48%134K-27.04%143K115.13%256K-41.58%111K50.77%787K9.30%282K79.82%196K67.61%119K126.19%190K
Operating revenue -22.24%605K-56.23%123K-32.31%132K105.04%244K-42.08%106K57.81%778K11.95%281K91.18%195K88.89%119K117.86%183K
Cost of revenue 25.92%583K-40.00%90K85.15%187K109.09%184K-1.61%122K55.37%463K16.28%150K17.44%101K31.34%88K726.67%124K
Gross profit -81.17%61K-66.67%44K-146.32%-44K132.26%72K-116.67%-11K44.64%324K2.33%132K313.04%95K675.00%31K-4.35%66K
Operating expense -18.25%12.33M-18.24%2.29M-29.61%2.95M-4.91%3.29M-17.95%3.8M-17.88%15.08M-33.80%2.8M-4.66%4.19M-43.91%3.46M29.69%4.63M
Selling and administrative expenses -12.87%9.27M-17.03%1.63M-35.28%2.2M4.39%2.57M1.95%2.87M-12.61%10.64M-17.21%1.97M18.68%3.39M-48.12%2.46M28.31%2.82M
Research and development costs -30.97%2.94M-18.14%650K-3.86%722K-28.23%684K-49.77%886K-28.85%4.26M-56.08%794K-49.56%751K-30.79%953K34.04%1.76M
Depreciation amortization depletion -35.36%117K-80.00%8K-31.91%32K-19.15%38K-17.02%39K-9.50%181K-14.89%40K-2.08%47K-4.08%47K-17.54%47K
-Depreciation and amortization -35.36%117K-80.00%8K-31.91%32K-19.15%38K-17.02%39K-9.50%181K-14.89%40K-2.08%47K-4.08%47K-17.54%47K
Operating profit 16.87%-12.27M15.85%-2.25M26.90%-2.99M6.15%-3.22M16.52%-3.81M18.65%-14.76M34.93%-2.67M6.33%-4.1M44.37%-3.43M-30.36%-4.56M
Net non-operating interest income expense 130.82%257K0107.40%68K89K100K-834K85K-919K00
Total other finance cost -130.82%-257K--0-107.40%-68K---89K---100K--834K---85K--919K--------
Other net income (expense) 107.89%3.16M152.17%1.2M-118.49%-737K490.00%1.48M457.80%1.22M15,110.00%1.52M-2.3M1,369.11%3.99M-305.41%-380K56.83%218K
Gain on sale of security 42.71%3.24M148.87%1.13M-112.34%-585K490.00%1.48M460.37%1.22M22,610.00%2.27M---2.31M1,610.19%4.74M-305.41%-380K56.12%217K
Special income (charges) 79.00%-159K--079.00%-159K-----------757K--0---757K--------
-Less:Impairment of capital assets -79.00%159K--0-79.00%159K----------757K--0--757K--------
Other non- operating income (expenses) 1,042.86%80K1,116.67%73K--7K----------7K--6K----------1K
Income before tax 37.11%-8.85M78.61%-1.05M-255.63%-3.66M56.75%-1.65M42.61%-2.49M22.39%-14.07M-19.11%-4.89M78.02%-1.03M36.30%-3.81M-29.27%-4.35M
Income tax 0000000000
Net income 37.11%-8.85M78.61%-1.05M-255.63%-3.66M56.75%-1.65M42.61%-2.49M22.39%-14.07M-19.11%-4.89M78.02%-1.03M36.30%-3.81M-29.27%-4.35M
Net income continuous Operations 37.11%-8.85M78.61%-1.05M-255.63%-3.66M56.75%-1.65M42.61%-2.49M22.39%-14.07M-19.11%-4.89M78.02%-1.03M36.30%-3.81M-29.27%-4.35M
Minority interest income
Net income attributable to the parent company 37.11%-8.85M78.61%-1.05M-255.63%-3.66M56.75%-1.65M42.61%-2.49M22.39%-14.07M-19.11%-4.89M78.02%-1.03M36.30%-3.81M-29.27%-4.35M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 37.11%-8.85M78.61%-1.05M-255.63%-3.66M56.75%-1.65M42.61%-2.49M22.39%-14.07M-19.11%-4.89M78.02%-1.03M36.30%-3.81M-29.27%-4.35M
Basic earnings per share 72.07%-14.5688.71%-0.96-89.31%-5.4993.81%-392.17%-4.585.87%-52.1387.02%-8.597.11%-2.962.40%-48.530.30%-57.5
Diluted earnings per share 72.07%-14.5688.71%-0.96-89.31%-5.4993.81%-392.17%-4.585.87%-52.1387.02%-8.597.11%-2.962.40%-48.530.30%-57.5
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----------Unqualified Opinion with Explanatory Notes--------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg